-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Ovid Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from Q3 2017 to Q3 2024.
- Ovid Therapeutics Inc. Return On Equity for the quarter ending September 30, 2024 was -39.2 %, a 5.94% increase year-over-year.
- Ovid Therapeutics Inc. annual Return On Equity for 2023 was -49.8 %, a 35.8% decline from 2022.
- Ovid Therapeutics Inc. annual Return On Equity for 2022 was -36.6 %, a 160% decline from 2021.
- Ovid Therapeutics Inc. annual Return On Equity for 2021 was 61.1 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)